1. Introduction {#sec0005}
===============

The South American camelids (SACs) are a group of artiodactyl mammals of the family Camelidae which includes alpacas (*Vicugna pacos*), guanacos (*Lama guanicoe*), llamas (*Lama glama*), and vicuñas (*Vicugna vicugna*). Alpacas, the smallest domestic SAC, are primarily distributed in Peru, with smaller populations in Bolivia, Chile and Ecuador, where they are a major source of fiber and meat. There are also numerous alpaca farms in the USA, Australia, New Zealand and different European countries as consequence of their exportation from Peru. As with most other ruminant species, they are at increased risk of acquiring infections of diverse aetiology during the first months of life, and diarrhoea is an important cause of morbidity and mortality in neonatal animals. The most common pathogens causing diarrhoea in neonatal SACs are coronavirus, *Escherichia coli*, *Cryptosporidium* spp., *Giardia duodenalis* and coccidia ([@bib0025], [@bib0145]).

*Giardia* and *Cryptosporidium* are two genera of protozoan parasites that infect humans, domesticated livestock, companion animals and wildlife worldwide ([@bib0155]). *G. duodenalis* is considered a multispecies complex infecting humans and many other species of mammals. Using a variety of genetic loci, eight genetic groups or assemblages (A → H) of *G. duodenalis* have been recognised: assemblages A and B from humans and many other mammals; assemblages C and D from dogs; assemblage E from artiodactyls; assemblage F from cats; assemblage G from rodents; and assemblage H from seals ([@bib0050]).

The genus *Cryptosporidium* currently comprises 19 valid species and over 40 genotypes ([@bib0040]). Ruminants can be infected by several *Cryptosporidium* species, being *Cryptosporidium parvum* the most commonly found. Together with *Cryptosporidium hominis*, this species is responsible for the majority of human infections. However, in some areas, such as Peru, *Cryptosporidium meleagridis* infection rates are as high as those of *C. parvum* ([@bib0020], [@bib0150]).

These parasites have been previously reported in SAC, including alpacas ([@bib0130], [@bib0135]). However, despite their economic importance, little information is available, and few studies have used molecular methods to characterise the *Giardia* and *Cryptosporidium* involved in the infections. The aim of the present study was to investigate the presence of *Giardia* and *Cryptosporidium* in alpacas from the Peruvian altiplano, applying molecular tests to characterise the isolates.

2. Materials and methods {#sec0010}
========================

2.1. Faecal samples {#sec0015}
-------------------

Between the years 2009 and 2010, a total of 274 faecal samples were collected directly from the rectums of suri (silky-haired) and huacaya (crimped-haired) breed alpacas (*V. pacos*), selected at random from 12 herds located in the Puno and Cusco regions of the Peruvian altiplano ([Table 1](#tbl0005){ref-type="table"} ).Table 1Prevalence of *Giardia* and *Cryptosporidium* in alpacas from Peru and assemblages or species identified.Analysed samples (*n*)*GiardiaCryptosporidium*Positive samples (%)Intensity of infection[a](#tblfn0005){ref-type="table-fn"}Molecular characterisation (A/E)[b](#tblfn0010){ref-type="table-fn"} (%A)[c](#tblfn0015){ref-type="table-fn"}Positive samples (%)Intensity of infection[a](#tblfn0005){ref-type="table-fn"}Molecular characterisation (species)Herd  1217 (33.3)1.90/3 (0.0)1 (4.8)1*C. ubiquitum*  23021 (70.0)2.45/9 (35.7)1 (3.3)1--  3221 (4.5)1.01/0 (100.0)0 (0.0)----  4149 (64.3)1.41/4 (20.0)1 (7.1)1--  53816 (42.1)1.66/1 (85.7)0 (0.0)----  680 (0.0)----1 (12.5)1--  721 (50.0)1.01/0 (100)0 (0.0)----  84326 (60.5)2.417/3 (85.0)3 (7.0)1--  9112 (18.2)1.51/0 (100)0 (0.0)----  102215 (68.2)1.612/0 (100)3 (13.6)1*C. parvum*  113524 (68.6)2.716/2 (88.9)1 (2.9)1--  1286 (75.0)2.52/0 (100)0 (0.0)---- No data209 (45.0)2.15/2 (71.4)1 (5.0)1*C. parvum*Age (weeks)  173 (42.9)1.72/0 (100)0 (0.0)----  293 (33.3)2.00/2 (0.0)0 (0.0)----  3142 (14.3)2.01/0 (100)0 (0.0)----  44520 (44.4)2.211/3 (78.6)0 (0.0)----  53317 (51.5)2.710/2 (83.3)3 (9.1)1--  67647 (61.8)2.028/4 (87.5)5 (6.6)1*C. parvum*  785 (62.5)2.82/0 (100)0 (0.0)----  854 (80.0)2.81/2 (33.3)1 (20.0)1--  920 (0.0)----0 (0.0)----  1084 (50.0)1.31/1 (50.0)0 (0.0)----  \>10357 (20.0)1.90/3 (0.0)2 (5.7)1*C. ubiquitum* No data3225 (78.1)2.011/7 (61.1)1 (3.1)1*C. parvum*Breed Huacaya14078 (55.7)2.041/14 (74.5)6 (4.3)1*C. parvum* Suri7535 (46.7)2.320/3 (87.0)3 (4.0)1-- No data5924 (40.7)2.26/7 (46.2)3 (5.1)1*C. parvum*/*C. ubiquitum*Sex Female12152 (43.0)2.122/14 (61.1)6 (5.0)1*C. ubiquitum* Male9345 (48.4)2.425/5 (83.3)2 (2.2)1-- No data6040 (66.7)2.120/5 (80.0)4 (6.7)1*C. parvum*Diarrhoeic processes Absence18484 (45.7)2.438/13 (74.5)7 (3.8)1-- Presence7644 (57.9)1.724/9 (72.7)4 (5.3)1*C. parvum* No data149 (64.3)2.15/2 (71.4)1 (7.1)1*C. parvum*/*C. ubiquitum* Total274137 (50.0)2.167/24 (73.6)[d](#tblfn0020){ref-type="table-fn"}12 (4.4)1[^1][^2][^3][^4]

After collection, aliquots of the faecal samples were resuspended in distilled water, put into screw top specimen cups, labelled with the animal identification and sent to the laboratory of Animal Health and Zoonoses (SALUVET) research group (Madrid, Spain). Data regarding sampling location, age, breed, sex and presence or absence of diarrhoeic processes were also recorded when possible.

2.2. Detection of *Giardia* cysts and *Cryptosporidium* oocysts by epifluorescence microscopy {#sec0020}
---------------------------------------------------------------------------------------------

Immunofluorescence staining was performed using the *Crypto/Giardia* Cel IF Test (Cellabs Pty Ltd., Brookvale, Australia) according to the manufacturer\'s instructions. The cysts/oocysts were identified by epifluorescence microscopy at 400× magnification on the basis of their size, shape and the pattern and intensity of immunofluorescence staining.

For detection, the whole slide was examined and the intensity of infection was determined semi-quantitatively according to the average number of parasitic forms in 10 randomly selected microscopic fields at 400× magnification: 0 (no cysts/oocysts), 1 (1 cyst/oocyst), 2 (2--5 cysts/oocysts), 3 (6--10 cysts/oocysts) and 4 (≥10 cysts/oocysts).

2.3. Molecular characterisation of *Giardia* spp. and *Cryptosporidium* spp. {#sec0025}
----------------------------------------------------------------------------

Nucleic acids were extracted from the faecal samples as described by [@bib0070]. Briefly, 200 μl of the sample was mechanically disrupted in the presence of guanidinium thiocyanate with zirconia beads using a Bead-Beater-8™ (BioSpec Products, Inc., Batlesville, OK, USA) and the DNA released from disrupted cysts/oocysts was purified using coarse activated silica and stored at −20 °C until use.

For the molecular characterisation of *Giardia* isolates, two nested PCR protocols were used to amplify fragments of 292 bp and 510 bp of the ssu-rRNA and β-giardin genes, respectively ([@bib0005], [@bib0065]). For *Cryptosporidium*, a two-step nested PCR protocol amplifying a fragment of 819--825 bp of the ssu-rRNA was employed ([@bib0160]). Negative and positive controls were included for all PCR runs. The PCR products were subjected to electrophoresis on 1% agarose/ethidium bromide gels.

PCR products were purified using GeneClean^®^ Turbo Kit (Qbiogene, Inc., Carlsbad, CA, USA) and sequenced in both directions using the forward and reverse inner primers with the Big Dye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) and a 3730 DNA analyser (Applied Biosystems) at the Unidad Genómica del Parque Científico de Madrid. Sequence data was examined using SeqMan^®^ 7.0 (DNASTAR^®^, Madison, WI, USA) and BioEdit 7.0.5.3 (^®^1997--2005 Tom Hall, Ibis Therapeutics, Carlsbad, CA, USA). The resulting sequences were compared with those of *Giardia* spp. and *Cryptosporidium* spp. deposited in GenBank (National Institutes of Health, Bethesda, MD, USA) using the program BLAST v.2.2.12 (<http://www.ncbi.nlm.nih.gov/BLAST/>, National Center for Biotechnology Information, Bethesda, MD, USA). Phylogenetic and molecular evolutionary analyses were made using MEGA 5 ([@bib0120]) on the basis of genetic distances calculated by the Kimura two-parameter model ([@bib0055]).

2.4. Statistical analysis {#sec0030}
-------------------------

Prevalence data with respect to breed, age, sex and presence or absence of diarrhoeic processes were analysed using the Chi-square or Fisher\'s exact test. Intensity of infection was analysed by the Kruskal--Wallis test (non-parametric anova) using the GraphPad Instat^®^, version 3.05, statistical software (©1992--2000 GraphPad Software, La Jolla, CA, USA). Differences were considered significant at a probability level of *P*  \< 0.05.

2.5. Nucleotide sequence accession numbers {#sec0035}
------------------------------------------

The nucleotide sequences of the isolates analysed in this study have been deposited in the GenBank database under accession numbers JN812214--JN812336.

3. Results {#sec0040}
==========

The application of immunofluorescence microscopy and PCR techniques on 274 alpaca faecal samples showed that 137 animals (50.0%) were infected by *Giardia* spp. and 12 animals by *Cryptosporidium* spp. (4.4%) ([Table 1](#tbl0005){ref-type="table"}). In 10 of these samples (3.6%), co-infection by both pathogens was found.

*Giardia* was detected in 11/12 herds examined (91.7%), with intra-herd prevalence ranging from 18.2% to 75%. The intensity of infection varied between 1.0 and 2.7. Although *Giardia* was detected in animals as young as 1 week, the prevalence and the intensity of infection increased with age reaching 80% and 2.8, respectively, at 8 weeks. Prevalence values of 50% and 20% were observed in animals 10 weeks and older than 10 weeks of age, respectively, but at lower intensities of infection. No statistically significant differences in prevalence and intensity of infection were observed in relation to breed, sex, or the existence of diarrhoeic process.

By PCR amplification of fragments of the ssu-rRNA and β-giardin genes, 92 of the 274 analysed samples (33.6%) were positive for *Giardia*. Sequencing of amplicons showed the existence of *G. duodenalis* assemblage A in 67 samples; *G. duodenalis* assemblage E in 24 samples; and in one sample there was an inconsistency between the two molecular markers used. For the amplified fragment of the ssu-rRNA gene, 6 sequences were observed, two matched others deposited in GenBank and 4 were new sequences (one close to *G. duodenalis* assemblage A and 3 close to *G. duodenalis* assemblage E) ([Fig. 1](#fig0005){ref-type="fig"} ). For the amplified fragment of the β-giardin gene, 3 sequences were observed, one corresponding to *G. duodenalis* assemblage A and two to *G. duodenalis* assemblage E. All sequences showed several SNPs with respect to the sequences deposited in GenBank ([Fig. 2](#fig0010){ref-type="fig"} ).Fig. 1Phylogenetic relationships among *Giardia* species and assemblages inferred by a neighbour-joining analysis of a fragment of the ssu-rRNA gene sequence, based on genetic distances calculated by the Kimura two-parameter model. Numbers on branches are percentage bootstrap values (\>50%) from 1000 replicates.Fig. 2Phylogenetic relationships among *G. duodenalis* assemblages inferred by a neighbour-joining analysis of a fragment of the β-giardin gene sequence, based on genetic distances calculated by the Kimura two-parameter model. Numbers on branches are percentage bootstrap values (\>50%) from 1000 replicates.

Faecal samples containing both *G. duodenalis* assemblages A and E were detected in 5 herds, whereas 5 herds contained only assemblage A and one herd had only assemblage E. Overall, *G. duodenalis* assemblage A was identified in a higher percentage of samples (73.6%). No significant differences were observed in relation to breed, sex or the presence of diarrhoeic processes.

*Cryptosporidium* spp. oocysts were observed by immunofluorescence microscopy in 12 faecal samples (4.4%) from animals aged ≥5 weeks belonging to 7 herds (58.3%) ([Table 1](#tbl0005){ref-type="table"}). Intra-herd prevalence ranged from 2.9% to 13.6%, and the intensity of infection was very low (\<1 oocyst per field). By amplification of a fragment of the ssu-rRNA, *C. parvum* was identified in two samples and *C. ubiquitum* in one sample ([Fig. 3](#fig0015){ref-type="fig"} ).Fig. 3Phylogenetic relationships among *Cryptosporidium* species and genotypes inferred by a neighbour-joining analysis of a fragment of the ssu-rRNA gene sequence, based on genetic distances calculated by the Kimura two-parameter model. Numbers on branches are percentage bootstrap values (\>50%) from 1000 replicates.

4. Discussion {#sec0045}
=============

This work constitutes the first extensive study in which the presence of *Giardia* and *Cryptosporidium* was investigated in alpacas in their natural habitat (Peruvian altiplano). Currently, published data about these two protozoan parasites in alpacas is limited, involving mainly descriptions of clinical cases ([@bib0010], [@bib0095], [@bib0110], [@bib0140]); isolated cases ([@bib0035], [@bib0100], [@bib0105], [@bib0075], [@bib0090], [@bib0115]) or epidemiological studies performed at farms located in countries such as the USA and UK where these animals have been introduced ([@bib0025], [@bib0130], [@bib0135]).

In SAC, the first case of *Giardia* infection was described in 1987 in an asymptomatic young llama in Wisconsin ([@bib0060]). Subsequently, *Giardia* was identified as the enteropathogen involved in 18% of diarrhoea cases in unweaned llama and alpaca crias in Oregon ([@bib0025]). In addition, data collected between the years 1999 and 2004 from 58 clinical cases of diarrhoea in alpacas less than 4 months of age at Ohio State University revealed that 32.8% of the crias were positive for *Giardia* spp. ([@bib0145]). Recently, [@bib0130] reported the detection of *Giardia* by PCR analysis in 4.9% of the faecal samples from 61 adult alpacas and crias from two farms in Maryland. The 3 positive samples were obtained from 14 and 27 month old females and from a 13 week old male. In our study, immunofluorescence microscopy and PCR analysis of faecal samples from 274 alpacas originating from 12 herds has revealed a global prevalence of 50.0%, reaching 75.0% in some herds, and highlighting the elevated prevalence of *Giardia* in these domestic animals. Overall, high percentages (14.3--80.0%) of positive animals were found in all age groups, except 9 weeks in which the 2 samples analysed were negative. Infection rates over 50% were observed in animals of ages 5--10 weeks, and were also elevated in animals as young as 1 week old (42.9%) as well as in older animals, \>10 weeks (20.0%). These results are in agreement with data reported in a previous alpaca study for the same age group, 32.8% in animals \<8--9 weeks of age ([@bib0145]), as well as with the 15.6% found in llamas and alpacas between 4 and 17 weeks of age ([@bib0025]), although the percentages found here are superior. However, in llamas detection of *Giardia* was higher in animals 0--2 months of age (25.0%), followed by groups of 2--4 (12.5%), 4--12 (5.3%) and 13--24 (3.2%) months, not detecting the parasite in animals 25 to \>96 months of age ([@bib0085]).

*Cryptosporidium*, as *Giardia*, has been reported in alpacas in the few clinical reports or epidemiological studies performed outside South America. A prevalence of 8.8% was reported by the Veterinary Laboratory Agency Service in England and Wales in samples from alpaca and llama crias submitted for a diagnosis of diarrhoea between 1999 and 2005 ([@bib0135]). In addition, prevalences of 6.7% and 25.9% were observed in llama and alpaca crias with diarrhoea aged between 1--2 and 1--14 weeks, respectively, from USA ([@bib0025], [@bib0145]). In the present study, the total prevalence for *Cryptosporidium* was 4.4%, being present in 58.3% of the herds analysed although at very low intensity of infection. The low number of oocysts observed in the faecal samples (\<1 oocyst per microscopic field at 400× magnification) and the small amount of faecal sample available could account for the differences in detection observed in the present study between immunofluorescence microscopy and PCR. *Cryptosporidium* spp. oocysts were detected by microscopy in 12 faecal samples, whereas molecular characterisation could only be achieved in 3 of these samples. The highest intra-herd prevalence was 13.6%. In contrast to other studies, positive animals were found in age groups 5 (9.1%), 6 (6.6%), 8 (20%) and \>10 (5.7%) weeks old. However, *Cryptosporidium* was not detected in any of the 61 alpaca samples from two Maryland farms ([@bib0130]). This may be due to the age of the animals examined, since in this study, the age range was 10 weeks to 10 years of age.

*Giardia* and *Cryptosporidium* have been included amongst the most common pathogens causing diarrhoea in neonatal camelids ([@bib0025], [@bib0145], [@bib0140]). In the present work, it was not possible to establish this association although the prevalence for both *Giardia* and *Cryptosporidium* detected in diarrhoeic samples was slightly higher. The average intensity of infection observed in diarrhoeic samples, however, was equal to or lower than that observed in non-diarrhoeic samples. This may be due to the age of the animals (\>5 weeks in the case of *Cryptosporidium*) or to the dilution of the diarrhoeic faecal samples. Subclinical infection with *Giardia* and *Cryptosporidium* has been previously reported in alpacas ([@bib0130], [@bib0135]). In addition, *G. duodenalis* was reported in 3.4% of 354 asymptomatic llamas ([@bib0085]). [@bib0130] suggested that the absence of clinical signs could indicate that *Giardia* might not necessarily be pathogenic in alpacas. However, shedding of the resistant forms of these parasites can extend beyond the period of diarrhoea and excretion is intermittent ([@bib0015], [@bib0125]), therefore the time at which samples are collected and the number of samples analysed per animal are critical to establish any association with diarrhoea. Nevertheless, subclinical shedding of cysts or oocysts has important implications at herd management level, since apparently healthy animals can be a source of infection to other animals in their vicinity.

Early molecular analysis of *Giardia* from alpacas in Australia (4 isolates) suggested that this host could be infected by assemblages A and E of *G. duodenalis* ([@bib0035]). Later, [@bib0130] identified *G. duodenalis* assemblage A in 3 of 61 animals examined and no assemblage E. In the present study, DNA sequence analysis revealed that amongst the 92 samples positive by PCR, 67 samples contained *G. duodenalis* assemblage A; 24 samples *G. duodenalis* assemblage E; and in the remaining sample there was an inconsistency between the two molecular markers used. These results show a clear predominance of the widely distributed zoonotic assemblage A in all age groups over assemblage E, which shows specificity to artiodactyl hosts.

The first studies in which *Cryptosporidium* isolates were characterised by molecular methods were those performed with the A1 alpaca isolate originating from Peru ([@bib0100], [@bib0105], [@bib0075]) and with an alpaca isolate from the Czech Republic ([@bib0090]), which showed consistent PCR, PCR-RFLP, and sequence analysis results for multiple loci with *C. parvum*. Later, this result was confirmed using several isolates from alpaca crias with and without diarrhoea in USA and UK ([@bib0110], [@bib0135]). Similarly, in the present study, *C. parvum* was identified in two animals. In addition, we describe here the presence, for the first time in this host, of *C. ubiquitum* in a female alpaca older than 10 weeks of age. This recently named *Cryptosporidium* species was previously identified as *Cryptosporidium* cervine genotype and occasionally as the cervid, W4 or genotype 3 genotype, and has been shown by molecular testing to infect the greatest number of host species of any species of *Cryptosporidium*, being found in domestic and wild ruminants, rodents and primates. *C. ubiquitum* has also been involved in human infections worldwide, including Peru ([@bib0045]).

In summary, this is the first study carrying out the molecular characterisation of a large number of *Giardia* isolates from alpacas, identifying for the first time *G. duodenalis* assemblages A and E in alpacas from the Peruvian altiplano. We also report for the first time the presence of *C. ubiquitum* in these populations. Because humans can be infected by *G. duodenalis* assemblage A, the high prevalence of *Giardia* detected, together with the identification of *C. parvum* and *C. ubiquitum* in these samples, suggests that zoonotic transmission of giardiosis and cryptosporidiosis between alpaca and humans can occur, and therefore these animals should be considered as potential sources of infection for humans. In fact, an outbreak of human cryptosporidiosis caused by *C. parvum* attributable to an alpaca source has been reported ([@bib0110]). Moreover, and due to the high prevalence of these two protozoan infections in humans in Peru ([@bib0030], [@bib0080]), the inverse situation may also occur. Further studies are therefore needed to investigate the epidemiology of these diseases in Peruvian alpacas.
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[^1]: Determined semiquantitatively according to the average number of parasitic forms in 10 randomly selected microscopic fields at 400× magnification: 0 (no cysts/oocysts), 1 (≤1 cyst/oocyst), 2 (2--5 cysts/oocysts), 3 (6--10 cysts/oocysts) and 4 (≥10 cysts/oocysts).

[^2]: *G*. *duodenalis* assemblage A or E.

[^3]: Percentage of samples in which the assemblage A of *G. duodenalis* was identified respect to the number of amplified samples.

[^4]: There was an incongruence between the two molecular markers used in one sample.
